The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation:A Meta-Analysis
Open accessAbstract
A systematic review of randomized clinical trials (RCT) was undertaken to evaluate the beneficial and harmful effects of immunosuppression with cyclosporin versus tacrolimus for liver transplanted patients. MEDLINE, EMBASE, Cochrane Central and Hepato-Biliary Group Controlled Trials Registers were searched. Using fixed and random effects model, relative risk (RR), values <1 favoring tacrolimus, with 95% confidence intervals (CI) were calculated. Of 717 potentially relevant references, 16 RCTs were eligible for inclusion. Mortality and graft loss at 1 year were significantly reduced in tacrolimus-treated recipients (Death: RR 0.85, 95% CI 0.73-0.99; graft loss: RR 0.73, 95% CI 0.61-0.86). Tacrolimus reduced the number of recipients with acute rejection (RR 0.81, 95% CI 0.75-0.88) and steroid-resistant rejection (RR 0.54, 95% CI 0.47-0.74) in the first year. Lymphoproliferative disorder or dialysis rates were not different but more de novo diabetes (RR 1.38, 95% CI 1.01-1.86) occurred with tacrolimus. More patients stopped cyclosporin than tacrolimus (RR 0.57, 95% CI 0.49-0.66). Treating 100 recipients with tacrolimus instead of cyclosporin would avoid rejection and steroid-resistant rejection in nine and seven patients respectively, graft loss and death in five and two patients respectively, but four additional patients would develop diabetes after liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
(1994) · New England Journal of Medicine · doi:10.1056/nejm199410273311702 · Cited by 920
(1994) · The Lancet · doi:10.1016/s0140-6736(94)91766-3 · Cited by 656
Webster, A. C., Woodroffe, R. C., Taylor, R. S., Chapman, J. R., & Craig, J. C. (2005) · BMJ · doi:10.1136/bmj.38569.471007.ae · Cited by 587
Knoll, G. A., & Bell, R. C. (1999) · BMJ · doi:10.1136/bmj.318.7191.1104 · Cited by 263
O'Grady, J., Burroughs, A., Hardy, P., Elbourne, D., & Truesdale, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11196-2 · Cited by 259
Cyclosporin versus tacrolimus for liver transplanted patients
Haddad, E., McAlister, V., Renouf, E., Malthaner, R., Kjaer, M. S., & Gluud, L. L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005161.pub2 · Cited by 259
Self-citationLevy, G. A., Villamil, F. G., Samuel, D., San-Juan, F., Grazi, G. L., Wu, Y., Marotta, P., Boillot, O., Muehlbacher, F., & Klintmalm, G. B. (2004) · Transplantation · doi:10.1097/01.tp.0000129095.51031.42 · Cited by 137
PREDNISONE WITHDRAWAL 14 DAYS AFTER LIVER TRANSPLANTATION WITH MYCOPHENOLATE
Stegall, M. D., Wachs, M. E., Everson, G. T., Steinberg, T. G., Bilir, B. M., Shrestha, R., Karrer, F. M., & Kam, I. (1997) · Transplantation · doi:10.1097/00007890-199712270-00023 · Cited by 132
Cited by
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
European evidence-based Consensus on the management of ulcerative colitis: Current management
Travis, S. P. L., Stange, E. F., Lémann, M., Øresland, T., Bemelman, W. A., Chowers, Y., Colombel, J. F., D'Haens, G., Ghosh, S., Marteau, P., et al. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2007.11.002 · Cited by 558
Neuberger, J. M., Bechstein, W. O., Kuypers, D. R. J., Burra, P., Citterio, F., De Geest, S., Duvoux, C., Jardine, A. G., Kamar, N., Krämer, B. K., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001651 · Cited by 315
Rodríguez-Perálvarez, M., Tsochatzis, E., Naveas, M. C., Pieri, G., García-Caparrós, C., O’Beirne, J., Poyato-González, A., Ferrín-Sánchez, G., Montero-Álvarez, J. L., Patch, D., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.012 · Cited by 264
A comprehensive review of immunosuppression used for liver transplantation
Mukherjee, S., & Mukherjee, U. (2009) · Journal of Transplantation · doi:10.1155/2009/701464 · Cited by 140
Metadata
- Authors
- McAlister, V. C., Haddad, E., Renouf, E., Malthaner, R. A., Kjaer, M. S., & Gluud, L. L.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 6
- Issue
- 7
- Pages
- 1578-1585
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W1576161048
- Cited by
- 263
- References
- 25
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation:A Meta-Analysis. https://app.cochat.ai/papers/10.1111/j.1600-6143.2006.01360.x
- The paper
- McAlister, V. C., Haddad, E., Renouf, E., Malthaner, R. A., Kjaer, M. S., & Gluud, L. L. (2006). Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation:A Meta-Analysis. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2006.01360.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.